يعرض 121 - 140 نتائج من 14,878 نتيجة بحث عن '(( significance ((nn decrease) OR (we decrease)) ) OR ( significant increase decrease ))', وقت الاستعلام: 0.63s تنقيح النتائج
  1. 121

    BMISES_Data_Part1. حسب Krystal Hunter (6820052)

    منشور في 2025
    الموضوعات:
  2. 122
  3. 123
  4. 124

    Diagram of study population. حسب Krystal Hunter (6820052)

    منشور في 2025
    الموضوعات:
  5. 125

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  6. 126

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  7. 127

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  8. 128
  9. 129

    Sociodemographic characteristics. حسب Hea Ree Park (10769827)

    منشور في 2024
    الموضوعات:
  10. 130

    Study flow chart. حسب Hea Ree Park (10769827)

    منشور في 2024
    الموضوعات:
  11. 131
  12. 132
  13. 133
  14. 134
  15. 135
  16. 136
  17. 137
  18. 138
  19. 139
  20. 140